EGI
OSIR

EAM Global Investors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

EAM Global Investors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-88,381
Closed -$1.19M – 182
2018
Q4 		$1.19M Buy
+88,381
New +$988K 0.65% 79

Other funds holding OSIR

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

EAM Global Investors's OSIR Position: Q1 2019 in Review

EAM Global Investors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2019, closing a stake of 88,381 shares — an estimated $1.19M sold.

EAM Global Investors first reported a position in OSIR in Q4 2018 and held it in 1 quarter. The position peaked at $1.19M in Q4 2018. 57 funds tracked by Wall St. Rank hold OSIR as of Q1 2019.

  • EAM Global Investors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • EAM Global Investors sold 88,381 Osiris Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $1.19M.
  • EAM Global Investors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • EAM Global Investors's Osiris Therapeutics, Inc. Common Stock position peaked at $1.19M in Q4 2018.
  • 57 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2019.

Based on EAM Global Investors's 13F filing for Q1 2019, filed 10 May 2019.